GSK China hit with record fine, apologizes
The China branch of British drug maker GlaxoSmithKline(GSK)has been fined 3 billion yuan(489 million U.S.dollars)for paying bribes, a verdict the firm"fully accepts"in an contrite statement.
GSK probe reveals bribes and lies
The bribery investigation of GlaxoSmithKline(GSK)China has been completed and the case handed over to prosecutors, Changsha police said on Wednesday.
Highlight
140 96副本.jpg
Eli Lilly mired in bribery scandal
Swiss drug maker tangled in bribery scandal
French drugmaker Sanofi under bribery probe
Bribery increases medicine prices by 20%: expert
GSK replaces China chief amid scandal